SUBSCRIBE
SUBSCRIBE

Preclinical

Drug Development
Too Much Light at Night May Lead To Obesity, Ohio State University Study Finds
October 12, 2010
 · 
1 min read
Drug Development
Deaf People ‘Can Rewire Brains’ , University of Western Ontario Study Claims
October 11, 2010
 · 
1 min read
Drug Development
Gene Study Could Hold Key to More Anti-Malaria Treatments, University of Edinburgh and New University of Lisbon Study
October 11, 2010
 · 
1 min read
Drug Development
Bones Restored With Dried Plum in Aging Mice, University of California, San Francisco (UCSF) Study
October 7, 2010
 · 
1 min read
Drug Development
Cancer Fighter Found in Marine Microbes, University of Florida Study
October 6, 2010
 · 
1 min read
Drug Development
Fish Oil Linked to Increased Risk of Colon Cancer in Mice, Michigan State University Study
October 6, 2010
 · 
1 min read
Drug Development
Scientists Find ‘Elixir of Life,’ Milan University Reveals
October 6, 2010
 · 
1 min read
Drug Development
Technique to Reattach Teeth Using Stem Cells Developed, University of Illinois Study
October 1, 2010
 · 
1 min read
Drug Development
Blueberries Help Fight Artery Hardening, Agricultural Research Service (ARS) and University of Arkansas Lab Animal Study Indicates
September 30, 2010
 · 
1 min read
Drug Development
Absent Mothers Can Cause Hyperactivity and Anxiety Later in Life, Yale University Reveals
September 30, 2010
 · 
1 min read
Load More
PRESS RELEASES
Business
Advanced Proteome Therapeutics Announces Appointment of Mr. Cory Brandolini to the Board of Directors
November 22, 2022
 · 
4 min read
Drug Development
Lantern Pharma Announces Positive Data Highlighting the Anti-Tumor Potency of Drug Candidate LP-184 for Glioblastoma at the Society for Neuro-Oncology Annual Meeting
November 22, 2022
 · 
7 min read
Drug Development
Scorpion Therapeutics to Present Preclinical Data for Potential Best-in-Class Mutant-Selective PI3Kα Inhibitor at San Antonio Breast Cancer Symposium
November 21, 2022
 · 
3 min read
Drug Development
Revelation Biosciences Inc. Announces Future Clinical Development Plans Based on Recent Biomarker Analysis and Significant Reduction in New Collagen Deposition (Fibrosis) in Preclinical Model
November 18, 2022
 · 
7 min read
Drug Development
Oncorus Presents Preclinical Data Supporting ONCR-719, an armed HSV-1 Vector engineered to use the Epidermal Growth Factor Receptor (EGFR/EGFRvIII) for viral entry in Glioblastoma, at the 2022 Society for Neuro-Oncology Annual Meeting
November 18, 2022
 · 
8 min read
Drug Development
MAIA Biotechnology Presents Preclinical Data at SITC Annual Meeting Validating Efficacy of THIO in Treating Hepatocellular Carcinoma
November 15, 2022
 · 
5 min read
Drug Development
Cerevance Announces Presentation of Preclinical Study Results at the Society for Neuroscience Conference
November 15, 2022
 · 
2 min read
Drug Development
GICELL Announces the Preclinical Research Data Demonstrating the Superiority of the NK Cell Mass Culture Platform at the Society for Immunotherapy of Cancer
November 14, 2022
 · 
3 min read
Drug Development
OncoNano Medicine Announces New Preclinical Data for ON-BOARD™ Platform for Delivery of Bispecific T Cell Engagers and a Therapeutic Cytokine at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 14, 2022
 · 
3 min read
Drug Development
Carisma Therapeutics Announces Clinical & Pre-Clinical Updates
November 11, 2022
 · 
13 min read
Drug Development
OncoResponse Announces Preclinical Data Highlighting OR2805 Discovery from Elite Responder Platform and OR502 anti-LILRB2 Antibody at SITC 2022
November 11, 2022
 · 
3 min read
Drug Development
TScan Therapeutics Presents Preclinical Data for Solid Tumor Program at the 37th Society for Immunotherapy of Cancer Annual Meeting
November 11, 2022
 · 
8 min read
Drug Development
Artiva Biotherapeutics Presents Preclinical Data for AB-101, an Optimized Allogeneic NK Cell Therapy Candidate, at SITC 2022 Annual Meeting
November 10, 2022
 · 
4 min read
Drug Development
CytoImmune Therapeutics to Present Preclinical Data Highlighting Potential of Novel TRACK-NK Cells to Selectively Target and Kill Hematologic and Solid Tumor Cancer Cells
November 10, 2022
 · 
3 min read
Drug Development
Celularity Presents Preclinical Data on CYNK-101, its Allogeneic Genetically-Modified Natural Killer Cell Therapy Candidate, at the Society for Immunotherapy of Cancer’s 37th Annual Meeting
November 10, 2022
 · 
5 min read
Drug Development
SQZ Biotechnologies Presents Cell Squeeze® Manufacturing Platform, Linked Antigen mRNA Preclinical Research, and COMMANDER-001 Phase 1/2 Clinical Trial in Progress Poster at Society for Immunotherapy of Cancer Annual Meeting
November 10, 2022
 · 
10 min read
Drug Development
Asher Bio Presents New Preclinical Data at SITC 2022 Further Supporting Advancement of AB248 and AB821 as Highly Differentiated Cis-targeted Cancer Immunotherapies
November 10, 2022
 · 
5 min read
Drug Development
IconOVir Announces New Preclinical Data Showcasing Best-in-Class Potential of ICVB-1042, its Lead Oncolytic Virus, at SITC 2022
November 10, 2022
 · 
5 min read
Drug Development
Codiak Presents Preclinical Data on exoASO™-STAT6 and exoASO™-C/EBPβ Programs at the Society for Immunotherapy of Cancer (SITC) 2022 Annual Meeting
November 10, 2022
 · 
9 min read
Drug Development
Sensei Biotherapeutics Presents Preclinical Data at the 37th Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10, 2022
 · 
6 min read
Load More